Eckhard Podack: Clinical Trials

1 trial sponsored by Eckhard Podack, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Eckhard Podack: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
gp96-Ig Vaccine, Theophylline, Oxygen - Non-Small Cell Lung Cancer, Non-small-cell Lung Carcinoma
Phase 1WithdrawnEckhard Podack2014-12-012014-11-17

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)

Interventions

Oxygen (1)  ·  Theophylline (1)  ·  glucose-regulated proteins (1)

Top investigators

Ikechukwu Akunyili, MD (1)